Theracryf PLC (TCF)

ORD 0.25P

Sell: 0.20p|Buy: 0.22p|Change: 0 (0%)

Open

0.21p

Previous close

0.21p

Trade high

0.213p

Volume

3,036,718

Year high

1.25p

Year low

0.175p

Dividend yield

–

Market capitalisation

£4.51 mn

P/E ratio

–

ISIN

GB00BSVYN304

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPPand can be used with Dividend reinvestment

Share price

Performance 31/01/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Theracryf PLC	0.00
FTSE AIM All Share	- 0.85
More...

Company profile

TheraCryf PLC is a clinical stage therapeutics company developing therapeutic candidates for behavioural brain disorders such as opioid and alcohol addiction, and acute/chronic fatigue. It focuses on data generation to support potential partnerships for its programs with mid-sized and large pharmaceutical companies. The company's pipeline includes Ox-1 - Substance Use Disorders (SUDs) / Anxiety, DAT - Fatigue and Narcolepsy, SFX-01, and SFX-01- Neurodevelopmental Disorders.

Sector

Healthcare

News

Recent trades

Date	Time	Price	Quantity	Value (£)
30/01/2026	04:06:11	0.2	3,000,000	6,000.00
30/01/2026	03:10:47	0.213	36,718	78.21
29/01/2026	03:11:12	0.2	27,878	55.76
29/01/2026	03:11:10	0.2	19,629	39.26
29/01/2026	03:11:10	0.2	4,000	8.00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.